Legal & General Group »

4d Molecular Therapeutics In shares owned by Legal & General Group

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Legal & General Group from 13F filings

Historical chart of Legal & General Group investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Legal & General Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $497k 25k 20.26
2023-09-30 $311k 24k 12.73
2023-06-30 $437k 24k 18.07
2023-03-31 $122k 7.1k 17.19
2022-12-31 $63k 2.8k 22.21
2022-09-30 $75k 9.4k 8.00
2022-06-30 $66k 9.4k 7.01
2022-03-31 $125k 8.2k 15.18
2021-12-31 $181k 8.2k 21.92
2021-09-30 $149k 5.5k 27.08
2021-06-30 $20k 814 24.57
2021-03-31 $34k 792 42.93